Human CUX2/CDP2/CUTL2 ORF/cDNA clone-Adenovirus plasmid (NM_001370598.1)

Cat. No.: pGMAD001341
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human CUX2/CDP2/CUTL2 adenoviral expression plasmid for CUX2 adenovirus packaging, CUX2 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to CUX2/CDP2 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAD001341
Gene Name CUX2
Accession Number NM_001370598.1
Gene ID 23316
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 4275 bp
Gene Alias CDP2,CUTL2,DEE67,EIEE67
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGGTGGCTCCTGTATTAAAAAGCTTCCAAGCCGAGGTGGTGGCCCTTAGTAAGAGAAGTCAGGAGGCGGAGGCTGCTTTTCTGAGTGTTTACAAGCAATTAATTGAAGCACCAGACCCCGTGCCTGTGTTTGAGGCGGCACGCAGCCTAGACGACAGACTGCAGCCCCCCAGCTTTGACCCCAGTGGGCAGCCCCGGCGAGACCTCCACACTTCGTGGAAGAGGAACCCCGAGCTCCTCAGCCCCAAAGAGCAGAGAGAGGGGACGTCGCCTGCCGGGCCCACGCTGACCGAGGGAAGCCGCCTCCCAGGCATTCCCGGGAAAGCCCTCCTGACAGAAACCTTGCTGCAGAGAAATGAGGCGGAAAAACAAAAGGGCCTTCAAGAAGTACAGATCACTTTGGCGGCCAGACTGGGGGAGGCAGAGGAGAAAATCAAAGTCCTACATTCAGCGCTAAAGGCTACGCAGGCAGAGCTGCTAGAGCTGCGGCGGAAGTACGACGAGGAGGCAGCATCCAAGGCAGATGAAGTCGGCCTGATCATGACCAACCTGGAGAAAGCTAATCAGCGAGCTGAGGCTGCCCAGCGGGAGGTGGAAAGTCTCCGGGAACAGCTGGCCTCTGTCAACAGCTCCATCCGCCTGGCTTGCTGCTCTCCCCAGGGGCCCAGTGGGGATAAGGTGAACTTCACTCTGTGCTCGGGCCCTCGGCTGGAGGCCGCGCTGGCCTCCAAGGACAGGGAGATCCTGCGGCTGCTGAAGGACGTGCAGCACCTCCAGAGCTCACTGCAGGAGCTGGAGGAGGCATCCGCCAACCAGATCGCCGACCTGGAGCGGCAGCTCACGGCCAAGTCCGAGGCCATAGAAAAGCTGGAAGAGAAGCTCCAGGCCCAGTCTGACTATGAGGAAATTAAAACGGAGCTGAGCATCCTGAAAGCCATGAAGCTGGCCTCCAGCACCTGCAGCCTCCCCCAGGGCATGGCCAAGCCTGAAGACTCACTGCTTATTGCAAAGGAGGCCTTCTTCCCCACGCAGAAATTCCTTCTGGAGAAGCCCAGCCTCCTGGCCAGCCCTGAGGAAGACCCATCAGAGGACGATTCCATCAAGGATTCACTGGGCACGGAGCAGTCCTACCCCTCCCCTCAGCAGCTCCCACCTCCACCAGGGCCAGAAGACCCCCTGTCTCCCAGCCCCGGGCAGCCCCTGCTGGGCCCCAGCTTGGGGCCTGACGGCACTCGGACTTTCTCGCTGTCCCCCTTCCCCAGCCTGGCATCAGGGGAGAGACTGATGATGCCCCCAGCCGCCTTCAAGGGAGAGGCGGGCGGCCTGCTGGTGTTCCCCCCAGCCTTCTATGGCGCCAAGCCCCCCACAGCCCCTGCCACCCCGGCCCCTGGCCCTGAGCCACTGGGCGGTCCTGAGCCCGCGGATGGTGGTGGGGGCGGAGCGGCGGGGCCCGGGGCAGAGGAGGAGCAGCTGGACACGGCAGAGATCGCCTTCCAGGTGAAGGAGCAGCTGCTGAAACACAACATCGGGCAGCGGGTGTTTGGGCATTACGTGCTGGGGCTGTCGCAGGGCTCGGTCAGCGAGATCCTAGCCCGGCCCAAGCCCTGGCGCAAGCTCACGGTGAAGGGCAAGGAGCCCTTCATCAAGATGAAGCAGTTCCTGTCGGATGAGCAGAATGTACTGGCGCTCAGGACCATCCAAGTGCGGCAGCGAGGCAGCATCACCCCGAGAATCCGCACGCCTGAGACAGGCTCAGACGACGCCATCAAGAGCATTCTAGAGCAGGCCAAGAAGGAGATCGAGTCGCAGAAGGGCGGCGAGCCCAAGACCTCGGTGGCCCCGCTGAGCATCGCCAACGGCACGACCCCCGCCAGCACCTCGGAGGACGCCATCAAGAGCATCCTGGAGCAGGCACGCCGTGAGATGCAGGCGCAACAGCAGGCGCTGCTGGAGATGGAGGTGGCGCCCAGGGGCCGCTCGGTGCCCCCCTCGCCCCCGGAGCGGCCATCACTGGCCACCGCGAGCCAGAACGGGGCCCCGGCCTTGGTGAAGCAGGAGGAGGGCAGCGGGGGCCCCGCGCAGGCGCCGCTCCCGGTCCTGTCCCCCGCCGCCTTCGTGCAGAGCATCATCCGCAAGGTCAAGTCCGAGATCGGCGACGCCGGCTACTTCGACCACCACTGGGCCTCCGACCGCGGCCTGCTCAGCCGCCCCTACGCCTCCGTGTCGCCCTCGCTGTCCTCCTCCTCCTCCTCTGGCTACTCTGGCCAGCCCAACGGCCGCGCCTGGCCCCGCGGGGACGAGGCCCCTGTGCCCCCCGAGGACGAGGCGGCGGCAGGGGCGGAGGACGAACCCCCCAGGACGGGCGAGCTCAAGGCTGAGGGCGCGACGGCCGAGGCGGGCGCGCGGCTGCCCTACTACCCGGCCTACGTGCCGCGCACCCTGAAGCCCACCGTGCCGCCGCTGACCCCCGAGCAGTACGAGCTGTACATGTACCGTGAGGTAGACACGCTGGAGCTCACCCGCCAGGTCAAGGAGAAGCTGGCCAAGAACGGCATCTGCCAGAGGATCTTCGGGGAGAAGGTGCTGGGCCTGTCACAGGGCAGCGTGAGCGACATGCTGTCCCGGCCGAAGCCATGGAGCAAGCTGACGCAGAAGGGGCGGGAGCCCTTCATCCGCATGCAGCTGTGGCTCTCTGACCAGCTCGGCCAGGCAGTGGGCCAGCAGCCTGGTGCCTCCCAGGCCAGTCCCACAGAACCAAGGTCCTCACCATCCCCACCCCCCAGCCCCACAGAGCCTGAGAAGAGCTCCCAGGAGCCGTTGAGCCTGTCCCTGGAGAGCAGCAAGGAGAACCAGCAGCCAGAGGGCCGCTCCAGCTCCTCGTTGAGCGGGAAGATGTACTCAGGCAGCCAGGCCCCAGGGGGCATCCAGGAGATCGTGGCCATGTCCCCCGAGCTGGACACGTACTCCATCACCAAGAGGGTGAAGGAGGTCCTCACAGACAACAATCTAGGGCAGCGGCTGTTTGGGGAAAGCATCCTGGGTCTGACACAGGGCTCCGTGTCTGACCTGCTGTCCCGGCCCAAACCCTGGCACAAGCTGAGCCTGAAGGGGCGGGAGCCTTTTGTCCGCATGCAGCTGTGGCTCAATGACCCCCATAACGTGGAGAAGCTGAGGGATATGAAGAAGCTGGAGAAGAAAGCCTACCTGAAACGTCGCTATGGCCTCATCAGCACCGGCTCAGACAGTGAGTCCCCGGCCACCCGCTCAGAGTGCCCCAGCCCCTGCCTGCAGCCCCAGGACCTGAGCCTCCTGCAGATCAAGAAGCCCCGGGTGGTGCTGGCACCCGAGGAGAAGGAGGCACTGCGGAAGGCCTATCAGCTGGAACCCTACCCCTCGCAGCAGACCATCGAGCTCCTCTCCTTCCAGCTCAACCTCAAGACCAACACCGTCATCAACTGGTTCCACAACTACAGGTCCCGGATGCGCCGGGAGATGTTGGTGGAGGGGACCCAGGATGAGCCAGACCTTGATCCAAGCGGGGGTCCTGGAATCCTACCGCCAGGCCACTCCCACCCAGACCCCACCCCGCAGAGCCCTGACTCTGAGACTGAGGACCAGAAGCCAACCGTGAAGGAACTGGAGCTTCAGGAGGGCCCTGAGGAGAACAGCACACCCCTGACCACCCAGGACAAGGCCCAAGTGAGGATCAAGCAGGAACAGATGGAGGAGGATGCTGAGGAAGAGGCAGGCAGCCAGCCCCAGGACTCAGGGGAGCTGGACAAAGGCCAAGGTCCCCCCAAAGAGGAGCATCCCGACCCTCCGGGTAATGATGGACTCCCAAAAGTGGCTCCCGGGCCCCTCCTTCCAGGTGGATCCACCCCAGACTGTCCCTCACTTCATCCCCAACAGGAGAGTGAGGCCGGGGAGCGACTTCACCCGGACCCTTTAAGTTTTAAGTCAGCCTCAGAGTCCTCACGCTGCAGCCTGGAGGTGTCACTGAACTCGCCCTCGGCCGCCTCCTCACCAGGCCTCATGATGTCTGTGTCACCTGTCCCCTCCTCCTCAGCTCCCATCTCCCCATCCCCACCTGGCGCCCCCCCTGCCAAAGTGCCGAGTGCCAGCCCCACTGCTGACATGGCTGGAGCCTTGCACCCCAGTGCCAAGGTGAACCCCAACTTGCAGCGGCGGCATGAGAAGATGGCCAATCTGAACAACATCATTTACCGAGTAGAGCGGGCTGCCAATCGGGAGGAGGCCCTGGAGTGGGAGTTCTGA
ORF Protein Sequence MVAPVLKSFQAEVVALSKRSQEAEAAFLSVYKQLIEAPDPVPVFEAARSLDDRLQPPSFDPSGQPRRDLHTSWKRNPELLSPKEQREGTSPAGPTLTEGSRLPGIPGKALLTETLLQRNEAEKQKGLQEVQITLAARLGEAEEKIKVLHSALKATQAELLELRRKYDEEAASKADEVGLIMTNLEKANQRAEAAQREVESLREQLASVNSSIRLACCSPQGPSGDKVNFTLCSGPRLEAALASKDREILRLLKDVQHLQSSLQELEEASANQIADLERQLTAKSEAIEKLEEKLQAQSDYEEIKTELSILKAMKLASSTCSLPQGMAKPEDSLLIAKEAFFPTQKFLLEKPSLLASPEEDPSEDDSIKDSLGTEQSYPSPQQLPPPPGPEDPLSPSPGQPLLGPSLGPDGTRTFSLSPFPSLASGERLMMPPAAFKGEAGGLLVFPPAFYGAKPPTAPATPAPGPEPLGGPEPADGGGGGAAGPGAEEEQLDTAEIAFQVKEQLLKHNIGQRVFGHYVLGLSQGSVSEILARPKPWRKLTVKGKEPFIKMKQFLSDEQNVLALRTIQVRQRGSITPRIRTPETGSDDAIKSILEQAKKEIESQKGGEPKTSVAPLSIANGTTPASTSEDAIKSILEQARREMQAQQQALLEMEVAPRGRSVPPSPPERPSLATASQNGAPALVKQEEGSGGPAQAPLPVLSPAAFVQSIIRKVKSEIGDAGYFDHHWASDRGLLSRPYASVSPSLSSSSSSGYSGQPNGRAWPRGDEAPVPPEDEAAAGAEDEPPRTGELKAEGATAEAGARLPYYPAYVPRTLKPTVPPLTPEQYELYMYREVDTLELTRQVKEKLAKNGICQRIFGEKVLGLSQGSVSDMLSRPKPWSKLTQKGREPFIRMQLWLSDQLGQAVGQQPGASQASPTEPRSSPSPPPSPTEPEKSSQEPLSLSLESSKENQQPEGRSSSSLSGKMYSGSQAPGGIQEIVAMSPELDTYSITKRVKEVLTDNNLGQRLFGESILGLTQGSVSDLLSRPKPWHKLSLKGREPFVRMQLWLNDPHNVEKLRDMKKLEKKAYLKRRYGLISTGSDSESPATRSECPSPCLQPQDLSLLQIKKPRVVLAPEEKEALRKAYQLEPYPSQQTIELLSFQLNLKTNTVINWFHNYRSRMRREMLVEGTQDEPDLDPSGGPGILPPGHSHPDPTPQSPDSETEDQKPTVKELELQEGPEENSTPLTTQDKAQVRIKQEQMEEDAEEEAGSQPQDSGELDKGQGPPKEEHPDPPGNDGLPKVAPGPLLPGGSTPDCPSLHPQQESEAGERLHPDPLSFKSASESSRCSLEVSLNSPSAASSPGLMMSVSPVPSSSAPISPSPPGAPPAKVPSASPTADMAGALHPSAKVNPNLQRRHEKMANLNNIIYRVERAANREEALEWEF

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP0630-Ab Anti-CUX2 monoclonal antibody
    Target Antigen GM-Tg-g-IP0630-Ag CUX2 protein
    ORF Viral Vector pGMAD001341 Human CUX2 Adenovirus plasmid
    ORF Viral Vector vGMAD001341 Human CUX2 Adenovirus particle


    Target information

    Target ID GM-IP0630
    Target Name CUX2
    Gene ID 23316, 13048, 712795, 288665, 101081500, 486267, 524491, 100630554
    Gene Symbol and Synonyms 1700051K22Rik,CDP2,CUTL2,Cux-2,CUX2,DEE67,EIEE67
    Uniprot Accession O14529
    Uniprot Entry Name CUX2_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000111249
    Target Classification Not Available

    This gene encodes a protein which contains three CUT domains and a homeodomain; both domains are DNA-binding motifs. A similar gene, whose gene product possesses different DNA-binding activities, is located on chromosome on chromosome 7. Two pseudogenes of this gene have been identified on chromosomes 10 and 4. [provided by RefSeq, Jan 2013]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.